StocksMedium•4 November 2026•
1 min read
Ocugen Beats Q3 Sales Estimates by 77% as Revenue Reaches $1.95 Million
Key Facts
1Ocugen reported Q3 sales of $1.951 million, exceeding analyst estimates of $1.098 million by 77.69%.
2Adjusted earnings per share came in at $(0.06), matching the consensus analyst estimates.
3Revenue grew 11.36% year-over-year from $1.752 million in the prior-year quarter.
Ocugen reported Q3 2026 sales of $1.951 million, exceeding analyst estimates of $1.098 million by 77.69%. According to scanx.trade, the company's adjusted earnings per share came in at $(0.06), matching the consensus analyst estimates for the quarter.
Revenue grew 11.36% year-over-year from $1.752 million in the prior-year period. Regarding market performance, OCGN closed at $0.7452 on November 3, 2026, having traded between a day high of $0.7899 and a day low of $0.7317 during that session.